Seneca Biopharmaceuticals, Inc. (SNCA)

Seneca Biopharma, Inc.

Seneca Biopharma, Inc., (NASDAQ: SNCA) is a clinical-stage biopharmaceutical company developing novel treatments for diseases of unmet medical need. Seneca is in the process of finding and acquiring new assets, promising sciences and technologies that will provide meaningful therapies for patients.

About Us

Finding Promising New Science and Developing a Pipeline of Biopharmaceuticals

Seneca Biopharma is focused on finding promising new science and developing a pipeline of biopharmaceuticals and commercializing those products while creating value for our stakeholders.

Our Technology Platform & Pipeline

Identifying new opportunities: Seneca Bio is focused on the continued development of its current technologies and has also engaged a network of trusted experts and advisors to assist us in evaluating new technologies.

Our Pipeline

Contact Us

Do you have questions about our company, our efforts or partnership opportunities?

Press Releases or Events

Jan 25, 2021

Seneca Biopharma Regains Compliance with NASDAQ Listing Requirements

Jan 20, 2021

Seneca Biopharma, Inc. Announces Top Line Data from Phase 2 Clinical Study in China for the Treatment of Ischemic Stroke

Jan 13, 2021

Leading BioSciences Announces FDA Fast Track Designation Granted to LB1148 for the Treatment of Postoperative Gastrointestinal Dysfunction Associated with Pediatric Cardiovascular Surgery

View All News & Events

Email Sign Up

First Name

Last Name

Email Address

Contact Type:

Sign me up for:

Press Releases

Annual & Qtr Reports

Current Reports

Insider Transactions

Proxy Information

All Filings